aluates Reports

$ 0.0

Automative

Soft Capsules Drugs CMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-26A5716

Global Soft Capsules Drugs CMO Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Soft Capsules Drugs CMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-26A5716

Report

October 2024

Pages:106

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Catalent

Aenova

Nature's Bounty

Procaps

Patheon (Thermo Fisher Scientific)

IVC

EuroCaps

Captek

Strides Pharma Science

Lonza (Capsugel)

Soft Gel Technologies

Sirio Pharma

Soft Capsules Drugs CMO - Market Size

The global market for Soft Capsules Drugs CMO was estimated to be worth US$ 7651 million in 2023 and is forecast to a readjusted size of US$ 10760 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030

Soft Capsules Drugs CMO - Market

The company supply Softgel Capsule contract pharmaceutical manufacturing services

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Soft Capsules Drugs CMO, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Soft Capsules Drugs CMO by region & country, by Type, and by Application.

The Soft Capsules Drugs CMO market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soft Capsules Drugs CMO.

Market Segmentation

Scope of Soft Capsules Drugs CMO - Market Report

Report Metric	Details
Report Name	Soft Capsules Drugs CMO - Market
Forecasted market size in 2030	US$ 10760 million
CAGR	5.0%
Forecasted years	2024 - 2030
Segment by Type:	Gelatin Type Non-animal Type
Segment by Application	Health Supplements Pharmaceutical Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Catalent, Aenova, Nature's Bounty, Procaps, Patheon (Thermo Fisher Scientific), IVC, EuroCaps, Captek, Strides Pharma Science, Lonza (Capsugel), Soft Gel Technologies, Sirio Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Soft Capsules Drugs CMO manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Soft Capsules Drugs CMO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Soft Capsules Drugs CMO in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Soft Capsules Drugs CMO - Market size in 2030?

Ans: The Soft Capsules Drugs CMO - Market size in 2030 will be US$ 10760 million.

Who are the main players in the Soft Capsules Drugs CMO - Market report?

Ans: The main players in the Soft Capsules Drugs CMO - Market are Catalent, Aenova, Nature's Bounty, Procaps, Patheon (Thermo Fisher Scientific), IVC, EuroCaps, Captek, Strides Pharma Science, Lonza (Capsugel), Soft Gel Technologies, Sirio Pharma

What are the Application segmentation covered in the Soft Capsules Drugs CMO - Market report?

Ans: The Applications covered in the Soft Capsules Drugs CMO - Market report are Health Supplements, Pharmaceutical, Others

What are the Type segmentation covered in the Soft Capsules Drugs CMO - Market report?

Ans: The Types covered in the Soft Capsules Drugs CMO - Market report are Gelatin Type, Non-animal Type

Recommended Reports

Capsules & Fillers

Prescription & OTC Drugs

Specialty Pharmaceuticals

1 Market Overview

1.1 Soft Capsules Drugs CMO Product Introduction

1.2 Global Soft Capsules Drugs CMO Market Size Forecast

1.3 Soft Capsules Drugs CMO Market Trends & Drivers

1.3.1 Soft Capsules Drugs CMO Industry Trends

1.3.2 Soft Capsules Drugs CMO Market Drivers & Opportunity

1.3.3 Soft Capsules Drugs CMO Market Challenges

1.3.4 Soft Capsules Drugs CMO Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Soft Capsules Drugs CMO Players Revenue Ranking (2023)

2.2 Global Soft Capsules Drugs CMO Revenue by Company (2019-2024)

2.3 Key Companies Soft Capsules Drugs CMO Manufacturing Base Distribution and Headquarters

2.4 Key Companies Soft Capsules Drugs CMO Product Offered

2.5 Key Companies Time to Begin Mass Production of Soft Capsules Drugs CMO

2.6 Soft Capsules Drugs CMO Market Competitive Analysis

2.6.1 Soft Capsules Drugs CMO Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Soft Capsules Drugs CMO Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs CMO as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Gelatin Type

3.1.2 Non-animal Type

3.2 Global Soft Capsules Drugs CMO Sales Value by Type

3.2.1 Global Soft Capsules Drugs CMO Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Soft Capsules Drugs CMO Sales Value, by Type (2019-2030)

3.2.3 Global Soft Capsules Drugs CMO Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Health Supplements

4.1.2 Pharmaceutical

4.1.3 Others

4.2 Global Soft Capsules Drugs CMO Sales Value by Application

4.2.1 Global Soft Capsules Drugs CMO Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Soft Capsules Drugs CMO Sales Value, by Application (2019-2030)

4.2.3 Global Soft Capsules Drugs CMO Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Soft Capsules Drugs CMO Sales Value by Region

5.1.1 Global Soft Capsules Drugs CMO Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Soft Capsules Drugs CMO Sales Value by Region (2019-2024)

5.1.3 Global Soft Capsules Drugs CMO Sales Value by Region (2025-2030)

5.1.4 Global Soft Capsules Drugs CMO Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Soft Capsules Drugs CMO Sales Value, 2019-2030

5.2.2 North America Soft Capsules Drugs CMO Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Soft Capsules Drugs CMO Sales Value, 2019-2030

5.3.2 Europe Soft Capsules Drugs CMO Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Soft Capsules Drugs CMO Sales Value, 2019-2030

5.4.2 Asia Pacific Soft Capsules Drugs CMO Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Soft Capsules Drugs CMO Sales Value, 2019-2030

5.5.2 South America Soft Capsules Drugs CMO Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Soft Capsules Drugs CMO Sales Value, 2019-2030

5.6.2 Middle East & Africa Soft Capsules Drugs CMO Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Soft Capsules Drugs CMO Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Soft Capsules Drugs CMO Sales Value

6.3 United States

6.3.1 United States Soft Capsules Drugs CMO Sales Value, 2019-2030

6.3.2 United States Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Soft Capsules Drugs CMO Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Soft Capsules Drugs CMO Sales Value, 2019-2030

6.4.2 Europe Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Soft Capsules Drugs CMO Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Soft Capsules Drugs CMO Sales Value, 2019-2030

6.5.2 China Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

6.5.3 China Soft Capsules Drugs CMO Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Soft Capsules Drugs CMO Sales Value, 2019-2030

6.6.2 Japan Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Soft Capsules Drugs CMO Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Soft Capsules Drugs CMO Sales Value, 2019-2030

6.7.2 South Korea Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Soft Capsules Drugs CMO Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Soft Capsules Drugs CMO Sales Value, 2019-2030

6.8.2 Southeast Asia Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Soft Capsules Drugs CMO Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Soft Capsules Drugs CMO Sales Value, 2019-2030

6.9.2 India Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

6.9.3 India Soft Capsules Drugs CMO Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Catalent

7.1.1 Catalent Profile

7.1.2 Catalent Main Business

7.1.3 Catalent Soft Capsules Drugs CMO Products, Services and Solutions

7.1.4 Catalent Soft Capsules Drugs CMO Revenue (US$ Million) & (2019-2024)

7.1.5 Catalent Recent Developments

7.2 Aenova

7.2.1 Aenova Profile

7.2.2 Aenova Main Business

7.2.3 Aenova Soft Capsules Drugs CMO Products, Services and Solutions

7.2.4 Aenova Soft Capsules Drugs CMO Revenue (US$ Million) & (2019-2024)

7.2.5 Aenova Recent Developments

7.3 Nature's Bounty

7.3.1 Nature's Bounty Profile

7.3.2 Nature's Bounty Main Business

7.3.3 Nature's Bounty Soft Capsules Drugs CMO Products, Services and Solutions

7.3.4 Nature's Bounty Soft Capsules Drugs CMO Revenue (US$ Million) & (2019-2024)

7.3.5 Procaps Recent Developments

7.4 Procaps

7.4.1 Procaps Profile

7.4.2 Procaps Main Business

7.4.3 Procaps Soft Capsules Drugs CMO Products, Services and Solutions

7.4.4 Procaps Soft Capsules Drugs CMO Revenue (US$ Million) & (2019-2024)

7.4.5 Procaps Recent Developments

7.5 Patheon (Thermo Fisher Scientific)

7.5.1 Patheon (Thermo Fisher Scientific) Profile

7.5.2 Patheon (Thermo Fisher Scientific) Main Business

7.5.3 Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Products, Services and Solutions

7.5.4 Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Revenue (US$ Million) & (2019-2024)

7.5.5 Patheon (Thermo Fisher Scientific) Recent Developments

7.6 IVC

7.6.1 IVC Profile

7.6.2 IVC Main Business

7.6.3 IVC Soft Capsules Drugs CMO Products, Services and Solutions

7.6.4 IVC Soft Capsules Drugs CMO Revenue (US$ Million) & (2019-2024)

7.6.5 IVC Recent Developments

7.7 EuroCaps

7.7.1 EuroCaps Profile

7.7.2 EuroCaps Main Business

7.7.3 EuroCaps Soft Capsules Drugs CMO Products, Services and Solutions

7.7.4 EuroCaps Soft Capsules Drugs CMO Revenue (US$ Million) & (2019-2024)

7.7.5 EuroCaps Recent Developments

7.8 Captek

7.8.1 Captek Profile

7.8.2 Captek Main Business

7.8.3 Captek Soft Capsules Drugs CMO Products, Services and Solutions

7.8.4 Captek Soft Capsules Drugs CMO Revenue (US$ Million) & (2019-2024)

7.8.5 Captek Recent Developments

7.9 Strides Pharma Science

7.9.1 Strides Pharma Science Profile

7.9.2 Strides Pharma Science Main Business

7.9.3 Strides Pharma Science Soft Capsules Drugs CMO Products, Services and Solutions

7.9.4 Strides Pharma Science Soft Capsules Drugs CMO Revenue (US$ Million) & (2019-2024)

7.9.5 Strides Pharma Science Recent Developments

7.10 Lonza (Capsugel)

7.10.1 Lonza (Capsugel) Profile

7.10.2 Lonza (Capsugel) Main Business

7.10.3 Lonza (Capsugel) Soft Capsules Drugs CMO Products, Services and Solutions

7.10.4 Lonza (Capsugel) Soft Capsules Drugs CMO Revenue (US$ Million) & (2019-2024)

7.10.5 Lonza (Capsugel) Recent Developments

7.11 Soft Gel Technologies

7.11.1 Soft Gel Technologies Profile

7.11.2 Soft Gel Technologies Main Business

7.11.3 Soft Gel Technologies Soft Capsules Drugs CMO Products, Services and Solutions

7.11.4 Soft Gel Technologies Soft Capsules Drugs CMO Revenue (US$ Million) & (2019-2024)

7.11.5 Soft Gel Technologies Recent Developments

7.12 Sirio Pharma

7.12.1 Sirio Pharma Profile

7.12.2 Sirio Pharma Main Business

7.12.3 Sirio Pharma Soft Capsules Drugs CMO Products, Services and Solutions

7.12.4 Sirio Pharma Soft Capsules Drugs CMO Revenue (US$ Million) & (2019-2024)

7.12.5 Sirio Pharma Recent Developments

8 Industry Chain Analysis

8.1 Soft Capsules Drugs CMO Industrial Chain

8.2 Soft Capsules Drugs CMO Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Soft Capsules Drugs CMO Sales Model

8.5.2 Sales Channel

8.5.3 Soft Capsules Drugs CMO Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Catalent

Aenova

Nature's Bounty

Procaps

Patheon (Thermo Fisher Scientific)

IVC

EuroCaps

Captek

Strides Pharma Science

Lonza (Capsugel)

Soft Gel Technologies

Sirio Pharma

List of Tables

Table 1. Soft Capsules Drugs CMO Market Trends

Table 2. Soft Capsules Drugs CMO Market Drivers & Opportunity

Table 3. Soft Capsules Drugs CMO Market Challenges

Table 4. Soft Capsules Drugs CMO Market Restraints

Table 5. Global Soft Capsules Drugs CMO Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Soft Capsules Drugs CMO Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Soft Capsules Drugs CMO Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Soft Capsules Drugs CMO Product Type

Table 9. Key Companies Time to Begin Mass Production of Soft Capsules Drugs CMO

Table 10. Global Soft Capsules Drugs CMO Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs CMO as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Soft Capsules Drugs CMO Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Soft Capsules Drugs CMO Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Soft Capsules Drugs CMO Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Soft Capsules Drugs CMO Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Soft Capsules Drugs CMO Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Soft Capsules Drugs CMO Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Soft Capsules Drugs CMO Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Soft Capsules Drugs CMO Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Soft Capsules Drugs CMO Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Soft Capsules Drugs CMO Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Soft Capsules Drugs CMO Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Soft Capsules Drugs CMO Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Soft Capsules Drugs CMO Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Soft Capsules Drugs CMO Sales Value by Region (2019-2024) & (%)

Table 27. Global Soft Capsules Drugs CMO Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Soft Capsules Drugs CMO Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Soft Capsules Drugs CMO Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Soft Capsules Drugs CMO Sales Value, (2025-2030) & (US$ Million)

Table 31. Catalent Basic Information List

Table 32. Catalent Description and Business Overview

Table 33. Catalent Soft Capsules Drugs CMO Products, Services and Solutions

Table 34. Revenue (US$ Million) in Soft Capsules Drugs CMO Business of Catalent (2019-2024)

Table 35. Catalent Recent Developments

Table 36. Aenova Basic Information List

Table 37. Aenova Description and Business Overview

Table 38. Aenova Soft Capsules Drugs CMO Products, Services and Solutions

Table 39. Revenue (US$ Million) in Soft Capsules Drugs CMO Business of Aenova (2019-2024)

Table 40. Aenova Recent Developments

Table 41. Nature's Bounty Basic Information List

Table 42. Nature's Bounty Description and Business Overview

Table 43. Nature's Bounty Soft Capsules Drugs CMO Products, Services and Solutions

Table 44. Revenue (US$ Million) in Soft Capsules Drugs CMO Business of Nature's Bounty (2019-2024)

Table 45. Nature's Bounty Recent Developments

Table 46. Procaps Basic Information List

Table 47. Procaps Description and Business Overview

Table 48. Procaps Soft Capsules Drugs CMO Products, Services and Solutions

Table 49. Revenue (US$ Million) in Soft Capsules Drugs CMO Business of Procaps (2019-2024)

Table 50. Procaps Recent Developments

Table 51. Patheon (Thermo Fisher Scientific) Basic Information List

Table 52. Patheon (Thermo Fisher Scientific) Description and Business Overview

Table 53. Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Products, Services and Solutions

Table 54. Revenue (US$ Million) in Soft Capsules Drugs CMO Business of Patheon (Thermo Fisher Scientific) (2019-2024)

Table 55. Patheon (Thermo Fisher Scientific) Recent Developments

Table 56. IVC Basic Information List

Table 57. IVC Description and Business Overview

Table 58. IVC Soft Capsules Drugs CMO Products, Services and Solutions

Table 59. Revenue (US$ Million) in Soft Capsules Drugs CMO Business of IVC (2019-2024)

Table 60. IVC Recent Developments

Table 61. EuroCaps Basic Information List

Table 62. EuroCaps Description and Business Overview

Table 63. EuroCaps Soft Capsules Drugs CMO Products, Services and Solutions

Table 64. Revenue (US$ Million) in Soft Capsules Drugs CMO Business of EuroCaps (2019-2024)

Table 65. EuroCaps Recent Developments

Table 66. Captek Basic Information List

Table 67. Captek Description and Business Overview

Table 68. Captek Soft Capsules Drugs CMO Products, Services and Solutions

Table 69. Revenue (US$ Million) in Soft Capsules Drugs CMO Business of Captek (2019-2024)

Table 70. Captek Recent Developments

Table 71. Strides Pharma Science Basic Information List

Table 72. Strides Pharma Science Description and Business Overview

Table 73. Strides Pharma Science Soft Capsules Drugs CMO Products, Services and Solutions

Table 74. Revenue (US$ Million) in Soft Capsules Drugs CMO Business of Strides Pharma Science (2019-2024)

Table 75. Strides Pharma Science Recent Developments

Table 76. Lonza (Capsugel) Basic Information List

Table 77. Lonza (Capsugel) Description and Business Overview

Table 78. Lonza (Capsugel) Soft Capsules Drugs CMO Products, Services and Solutions

Table 79. Revenue (US$ Million) in Soft Capsules Drugs CMO Business of Lonza (Capsugel) (2019-2024)

Table 80. Lonza (Capsugel) Recent Developments

Table 81. Soft Gel Technologies Basic Information List

Table 82. Soft Gel Technologies Description and Business Overview

Table 83. Soft Gel Technologies Soft Capsules Drugs CMO Products, Services and Solutions

Table 84. Revenue (US$ Million) in Soft Capsules Drugs CMO Business of Soft Gel Technologies (2019-2024)

Table 85. Soft Gel Technologies Recent Developments

Table 86. Sirio Pharma Basic Information List

Table 87. Sirio Pharma Description and Business Overview

Table 88. Sirio Pharma Soft Capsules Drugs CMO Products, Services and Solutions

Table 89. Revenue (US$ Million) in Soft Capsules Drugs CMO Business of Sirio Pharma (2019-2024)

Table 90. Sirio Pharma Recent Developments

Table 91. Key Raw Materials Lists

Table 92. Raw Materials Key Suppliers Lists

Table 93. Soft Capsules Drugs CMO Downstream Customers

Table 94. Soft Capsules Drugs CMO Distributors List

Table 95. Research Programs/Design for This Report

Table 96. Key Data Information from Secondary Sources

Table 97. Key Data Information from Primary Sources

Table 98. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Soft Capsules Drugs CMO Product Picture

Figure 2. Global Soft Capsules Drugs CMO Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Soft Capsules Drugs CMO Sales Value (2019-2030) & (US$ Million)

Figure 4. Soft Capsules Drugs CMO Report Years Considered

Figure 5. Global Soft Capsules Drugs CMO Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Soft Capsules Drugs CMO Revenue in 2023

Figure 7. Soft Capsules Drugs CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Gelatin Type Picture

Figure 9. Non-animal Type Picture

Figure 10. Global Soft Capsules Drugs CMO Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Soft Capsules Drugs CMO Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Health Supplements

Figure 13. Product Picture of Pharmaceutical

Figure 14. Product Picture of Others

Figure 15. Global Soft Capsules Drugs CMO Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Soft Capsules Drugs CMO Sales Value Market Share by Application, 2023 & 2030

Figure 17. North America Soft Capsules Drugs CMO Sales Value (2019-2030) & (US$ Million)

Figure 18. North America Soft Capsules Drugs CMO Sales Value by Country (%), 2023 VS 2030

Figure 19. Europe Soft Capsules Drugs CMO Sales Value (2019-2030) & (US$ Million)

Figure 20. Europe Soft Capsules Drugs CMO Sales Value by Country (%), 2023 VS 2030

Figure 21. Asia Pacific Soft Capsules Drugs CMO Sales Value (2019-2030) & (US$ Million)

Figure 22. Asia Pacific Soft Capsules Drugs CMO Sales Value by Country (%), 2023 VS 2030

Figure 23. South America Soft Capsules Drugs CMO Sales Value (2019-2030) & (US$ Million)

Figure 24. South America Soft Capsules Drugs CMO Sales Value by Country (%), 2023 VS 2030

Figure 25. Middle East & Africa Soft Capsules Drugs CMO Sales Value (2019-2030) & (US$ Million)

Figure 26. Middle East & Africa Soft Capsules Drugs CMO Sales Value by Country (%), 2023 VS 2030

Figure 27. Key Countries/Regions Soft Capsules Drugs CMO Sales Value (%), (2019-2030)

Figure 28. United States Soft Capsules Drugs CMO Sales Value, (2019-2030) & (US$ Million)

Figure 29. United States Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

Figure 30. United States Soft Capsules Drugs CMO Sales Value by Application (%), 2023 VS 2030

Figure 31. Europe Soft Capsules Drugs CMO Sales Value, (2019-2030) & (US$ Million)

Figure 32. Europe Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

Figure 33. Europe Soft Capsules Drugs CMO Sales Value by Application (%), 2023 VS 2030

Figure 34. China Soft Capsules Drugs CMO Sales Value, (2019-2030) & (US$ Million)

Figure 35. China Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

Figure 36. China Soft Capsules Drugs CMO Sales Value by Application (%), 2023 VS 2030

Figure 37. Japan Soft Capsules Drugs CMO Sales Value, (2019-2030) & (US$ Million)

Figure 38. Japan Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

Figure 39. Japan Soft Capsules Drugs CMO Sales Value by Application (%), 2023 VS 2030

Figure 40. South Korea Soft Capsules Drugs CMO Sales Value, (2019-2030) & (US$ Million)

Figure 41. South Korea Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

Figure 42. South Korea Soft Capsules Drugs CMO Sales Value by Application (%), 2023 VS 2030

Figure 43. Southeast Asia Soft Capsules Drugs CMO Sales Value, (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

Figure 45. Southeast Asia Soft Capsules Drugs CMO Sales Value by Application (%), 2023 VS 2030

Figure 46. India Soft Capsules Drugs CMO Sales Value, (2019-2030) & (US$ Million)

Figure 47. India Soft Capsules Drugs CMO Sales Value by Type (%), 2023 VS 2030

Figure 48. India Soft Capsules Drugs CMO Sales Value by Application (%), 2023 VS 2030

Figure 49. Soft Capsules Drugs CMO Industrial Chain

Figure 50. Soft Capsules Drugs CMO Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Contract Bio manufacturing Organization CMO Market Insights Forecast to 2030

Global Pharmaceutical Products and CMO Market Research Report 2024

Global Pharmaceutical CMO Services Market Research Report 2024

Global CMO CDMO Market Insights Forecast to 2030

Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical Softgel Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biopharmaceutical CMO Services Market Research Report 2024

Healthcare Contract Development And Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical CXO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Contract Development and Manufacturing Market Insights Forecast to 2030

Global Chemical Drug CMO Market Research Report 2024

Pharmaceutical Contract Manufacturing and Contract Market

Medical Protective Face Shields Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Active Pharmaceutical Ingredients CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Contract Packaging Organizations CPOs Market Insights Forecast to 2030

Nutritional Supplements for Chronic Kidney Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Soft Capsule Manufacturing Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Contract Sales Organization CSO Market Research Report 2025

Global Soft Capsule Technology Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions